Board Meeting5 Nov 2026, 05:51 pm
Pharmaids Pharmaceuticals Ltd Board Meeting on Nov 11, 2026
AI Summary
Pharmaids Pharmaceuticals Ltd has announced that its Board of Directors will convene on November 11, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for both standalone and consolidated operations for the quarter and half-year ended September 30, 2026. Additionally, the company has informed that the trading window for its securities will remain closed from October 01, 2026, and will reopen 48 hours after the declaration of the financial results, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Key Highlights
- Board meeting scheduled for November 11, 2026.
- To approve Unaudited Financial Results for Q2 & H1 FY27.
- Results will be Standalone & Consolidated.
- Trading window closure from October 01, 2026.
- Trading window reopens 48 hours post results declaration.
Price Impact
More from PHARMAID